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Summary
Objectives: Recent data have suggested that macrophages are involved in the pathogenesis of discogenic back pain and enhance the
secretion of inﬂammatory mediators in co-cultured annulus ﬁbrosus (AF) cells. The purpose of these studies is to determine the role of
p38 mitogen-activated protein kinase (p38 MAPK) signaling in the interactions between macrophage and AF cells.
Methods: Human AF cells were co-cultured with phorbol myristate acetate-stimulated macrophage-like THP-1 cells with and without p38
MAPK inhibition. Conditioned media from co-cultured cells were assayed for interleukin (IL)-6, IL-8, prostaglandin E2 (PGE2), PGF2a, and
vascular endothelial growth factor (VEGF). Na€ıve and macrophage-exposed AF cell responses to 10 ng/ml tumor necrosis factor-a
(TNF-a) were compared using the same outcome measures.
Results: IL-6, IL-8, PGE2, PGF2a, and VEGF were secreted in greater quantities by cells maintained in co-culture compared to macrophages
or AF cells cultured alone. SB202190 blunted IL-6, PGE2, and PGF2a production in a dose-dependent manner in co-culture. However, it did
not suppress IL-8 and VEGF production. TNF-a-stimulated AF cell inﬂammatory mediators were up-regulated by macrophage exposure.
SB202190 successfully suppressed IL-6, IL-8, PGE2, and PGF2a secretion in macrophage-exposed AF cells in response to TNF-a.
Conclusions: Annular injury can result in macrophage inﬁltration, and this can cause enhanced inﬂammatory mediator and VEGF production
by AF cells. The p38 MAPK pathway signals are responsible for much of IL-6 and PG secretion from AF cells with macrophage-like cells,
suggesting that blockade of this signal may serve as a therapeutic approach to discogenic pain.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Low back pain is a common clinical problem of major so-
cioeconomic importance. One or more of the spinal struc-
tures, including intervertebral discs, facet joints, vertebral
bodies, ligaments and muscles, can be a source of low
back pain. Although discogenic pain initiated by tears in
the anulus is an important cause of chronic intractable
low back pain1,2, the mechanisms underlying its disease
pathogenesis are still unclear and deﬁnitive diagnostic
tools also remain controversial3. Painful symptomatic discs
in discogenic low back pain syndrome appear to result
from previous injury and biological repair of the outer*Address correspondence and reprint requests to: James D.
Kang, Ferguson Laboratory for Orthopaedic Research,
Department of Orthopaedic Surgery, University of Pittsburgh
School of Medicine, 200 Lothrop Street, E1641 BST, Pittsburgh,
PA 15261, USA. Tel: 1-412-605-3241; Fax: 1-412-383-5307;
E-mail: kangjd@upmc.edu
Received 6 April 2009; revision accepted 17 June 2009.
1662annulus ﬁbrosus (AF)1. Abundant macrophages were
strongly associated with inﬂammatory reactions, granula-
tion tissue formation, and repair processes in a study ex-
amining discs from patients with discogenic low back
pain1. We have shown that macrophages enhance secre-
tion of inﬂammatory mediators in AF cells2. Exposure to
macrophages is expected after annular injuries, and can
result in enhanced responses to local inﬂammation. This
suggests that inﬂammatory mediators are associated with
development of symptomatic discs.
We have developed and validated a reproducible in vitro
macrophage-AF cell co-culture model system that repre-
sents in vivo local inﬂammatory reactions after annular tear-
ing2. Cytokines are involved in the development of
inﬂammatory reactions and are responsible for the signiﬁ-
cant pathology of symptomatic discs, disc degeneration,
and pain. Among cytokines, interleukin (IL)-6 and IL-8 pro-
duction are orders of magnitude greater than tumor necro-
sis factor-a (TNF-a) and IL-1b in co-culture model
although much attention has been paid to the role of
TNF-a and IL-1b in disc disease2. Disc tissue IL-6 produc-
tion may contribute signiﬁcantly to neurogenic pain4, and
1663Osteoarthritis and Cartilage Vol. 17, No. 12IL-8 may be related to neovascularization and inﬂammatory
reactions in painful discs2. Prostaglandins (PGs) are bioac-
tive lipids which function as local mediators, and are primar-
ily involved in inﬂammation. PGE2 and PGF2a speciﬁcally
contribute to the initiation and maintenance of primary hy-
peralgesia5. Mechanical hyperalgesia produced by autolo-
gous nucleus pulposus has been successfully blocked by
phospholipase A2 (PLA2) inhibitors6. Thus, knowledge of
cytokine and PG production from AF cells is important for
a mechanistic evaluation of the processes involved in disco-
genic pain.
Vascular endothelial growth factor (VEGF) has strong an-
giogenic activity as well as speciﬁc mitogenic and chemo-
tactic effects on endothelial cells7. Hypoxia induces
cellular VEGF through the hypoxia inducible factor (HIF)-
1a pathway8. An in vitro acute herniated disc model demon-
strated strong VEGF expression by macrophages and disc
cells after TNF-a up-regulation9. Clinically, VEGF is ex-
pressed in the cartilage of osteoarthritis patients10 and is in-
duced in hypoxic conditions. This suggested that VEGF
could also be involved in the disc inﬂammatory reaction.
The mitogen-activated protein kinases (MAPKs) are an
evolutionally conserved family of molecules involved in
cell signaling and gene expression11. MAPKs are activated
by phosphorylation, and transduce a broad range of extra-
cellular stimuli into diverse intracellular responses by both
transcriptional and non-transcriptional regulation. The
MAPK family includes the extracellular signal-regulated ki-
nase (ERK), p38, and the c-Jun N-terminal kinase (JNK)
signaling cascades. Among them, p38 MAPK is considered
to be a central regulator of inﬂammation12. This kinase is
implicated in cyclooxygenase 2 (COX-2) induction/PGE2
synthesis, chondrocyte apoptosis, HIF-1a induction, and
transcription of multiple other factors that comprise inﬂam-
matory responses13,14. We recently reported that p38
MAPK is intimately involved in pro-inﬂammatory cytokine
induction of inﬂammatory mediators in human and rabbit
nucleus pulposus (NP) cells, which is similar to earlier ob-
servations in articular chondrocytes15,16. Rannou et al. sug-
gested that p38 MAPK signaling was involved in AF cell
apoptosis during mechanical overload17. We hypothesized
in this study that p38 MAPK blockade will diminish produc-
tion of pain-related inﬂammatory mediators and VEGF in
AF-macrophage co-culture model.MethodsAF CELL ISOLATION AND PELLET CULTUREHuman AF cells were isolated from disc tissues of six patients (two men
and four women) during elective degenerative spinal disease surgical proce-
dures. Tissue specimens were placed in sterile Ham’s F-12 medium (F-12,
GibcoBRL, Grand Island, NY) containing 1% penicillin/streptomycin (P/S,
Bio-Whittaker, Walekrsville, MD) and 5% fetal bovine serum (FBS, Gib-
coBRL, Grand Island, NY). AF tissue was washed three times with Hank’s
balance salt solution (HBSS, GibcoBRL, Grand Island, NY) with 1% P/S to
remove blood and other bodily contaminants prior to isolation. Specimens
were minced and digested for 60 min at 37C under gentle agitation in F-
12 medium containing 1% P/S, 5% FBS, and 0.2% pronase (Calbiochem,
La Jolla, CA). The specimens were rinsed three times with HBSS and 1%
P/S and were incubated overnight in a solution of F-12 medium containing
1% P/S, 5% FBS, and 0.025% collagenase type I (Sigma Chemical Co.,
St Louis, MO). A sterile nylon mesh ﬁlter (70 mm pore size) was used to sep-
arate suspended cells from the remaining tissue debris. Isolated cells were
centrifuged at 2000 RPM for 5 min, re-suspended in F-12 medium with
10% FBS and 1% P/S. Cells were placed in a 75 cm3 culture ﬂask (VWR Sci-
entiﬁc Products, Bridgeport, NJ) and incubated at 37C in a humidiﬁed atmo-
sphere of 5% carbon dioxide. Culture media were changed twice weekly, and
cultures grown to 95% conﬂuence. Conﬂuent cells were trypsinized, and AF
cells (2.5 105) were re-suspended in culture media. Cells were placed in
individual 15 ml polypropylene conical tubes with culture medium,centrifuged for 5 min at 2000 RPM to form pellet aggregates, and incubated
at 37C for 5 days with media changed every 2 or 3 days.ACTIVATED MACROPHAGE-LIKE THP-1 CELLS CULTUREThe human monocyte cell line THP-1 (ATCC TIB202; ATCC, Manassas,
VA) is part of the mononuclear phagocyte series and can be converted into
activated macrophages with phorbol myristate acetate (PMA) treatment. Ac-
tivated macrophages exhibit phagocytosis and produce inﬂammatory media-
tors including TNF-a, IL-1b, and IL-82,18e21. THP-1 cells were maintained in
RPMI 1640 (ATCC Manassas, VA) supplemented with 10% FBS, 1% P/S,
and 0.05 mM 2-mercaptoethanol (2-ME; Sigma Chemical Co., St. Louis,
MO). Monocytes were stimulated to differentiate into macrophage-like
THP-1 cells with 160 nM PMA (Sigma Chemical Co., St. Louis, MO) for
72 h prior to co-culture. All cells were incubated at 37C in air and 5% CO2.CO-CULTURE EXPERIMENTS [FIG. 1(A)]PMA activated macrophage-like THP-1 cells were removed from a culture
ﬂask after trypsinization (0.05% trypsin/ethylenediaminetetraacetic acid
(EDTA), GibcoBRL, Grand Island, NY), washed twice with HBSS and serum
starved medium (RPMI 1640 media, 1% P/S, 1% FBS, and 0.05 mM 2-ME),
and plated on a 24-well culture dish at a density of 2.5 105 cells/well in se-
rum starved media. AF pellet aggregates were added to cell culture inserts
(1 mm pore size, Becton Dickson Labware, Franklin Lakes, NJ) in the wells
containing macrophage-like cells. Both cell types were co-cultured for 72 h
with media in the presence of the p38 MAPK inhibitor SB202190 (Calbio-
chem, San Diego, CA) at 0.1 mM, 1 mM, and 10 mM. Conditioned media
(CM) were collected for the measurement of IL-6, IL-8, PGE2, PGF2a, and
VEGF production after 72 h growth. Results were expressed as the average
of three independent experiments.STIMULATION OF AF CELLS WITH TNF-a IN PRESENCE OF
SB202190 AFTER CO-CULTURE [FIG. 1(B)]AF pellets on cell inserts were washed twice with HBSS and serum
starved medium, and were moved to new 24-well culture dishes to study
macrophage-like cell inﬂuence of AF cell response to TNF-a with p38
MAPK inhibitor after 72 h co-culture. Pellets were maintained for 48 h with
media or with recombinant human TNF-a (10 ng/ml, Alexis Biochemicals,
San Diego, CA) and SB202190 (0.1 mM and 1 mM) and CM analyzed.BIOCHEMICAL ANALYSIS (ENZYME-LINKED IMMUNOSORBENT
ASSAY, ELISA)IL-6, IL-8, PGE2, PGF2a and VEGF media concentrations were assayed
by ELISA using commercially available kits (R and D Systems, Minneapolis,
MN) per the manufacturer’s instructions.DNA CONTENTDNA content was measured with the Pico green dsDNA Assay Kit (Molec-
ular Probes/Invitrogen, Grand Island, NY) per the manufacturer’s
instructions.STATISTICAL ANALYSISData were expressed as the mean standard error (SE) for three inde-
pendent experiments with independent cultures. One-way ANOVA was per-
formed with the between-subject factors for different treatments. Signiﬁcant
differences were deﬁned at P values <0.05.ResultsSECRETION OF INFLAMMATORY MEDIATORS IN CO-CULTUREIL-6 (238.7 19.4 ng/ml), PGE2 (36.7 6.3 ng/ml), and
PGF2a (5.0 1.5 ng/ml) concentrations were strikingly
increased in the co-culture group CM, while AF cell and
macrophage-like cells individually produced very low or
non-detectable amounts of inﬂammatory mediators
[Fig. 2(A, B)]. IL-8 levels demonstrated a 3-fold increase
in the CM of the co-culture group (101.5 16.5 ng/ml) com-
pared to macrophage-like cells alone (29.6 6.6 ng/ml).
Fig. 1. Schematic representation of the in vitro co-culture system using cell culture inserts. AF cells (2.5 105 cells/well); AFM, co-culture AF
cells with macrophage-like THP-1 cells (AF cells: 2.5 105 cells/well and macrophage-like THP-1 cells¼ 2.5 105 cells/well); M, macro-
phage-like THP-1 cells (2.5 105 cells); AF(U), macrophage-unexposed (na€ıve) AF cells; AF(M), macrophage-exposed cells. See Methods
for details.
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tain any detectable amount of IL-8.INHIBITORY EFFECT OF SB202190 ON INFLAMMATORY
MEDIATORS SECRETION IN CO-CULTURESB202190 (at 1 mM and 10 mM) decreased IL-6 in CM
from the co-cultured group but did not suppress IL-8 pro-
duction [Fig. 2(C)]. SB202190 at 1 mM and 10 mM caused
a 21% and 42% decrease in IL-6, respectively, in the co-cul-
tured group. 1 mM SB202190 is the inhibitor concentration
that is speciﬁc for p38 MAPK inhibition16. 0.1 mM
SB202190 concentration did not inhibit IL-6 production.
PGE2 and PGF2a accumulation were considerately de-
creased by 1 mM SB202190 (55% for PGE2 and 67% for
PGF2a) and were almost completely suppressed at 10 mM
SB202190 (89% for PGE2 and 94% for PGF2a) in the co-
culture group [Fig. 2(D)].TNF-a STIMULATED SECRETION OF INFLAMMATORY
MEDIATORS IN AF CELLSWe compared the concentrations of IL-6, IL-8, PGE2, and
PGF2a in the CM of na€ıve and macrophage-exposed AF
cells to conﬁrm the effects of macrophage-like cells effects
on AF cell response to 10 ng/ml TNF-a stimulation. 10 ng/
ml TNF-a is previously shown to trigger inﬂammatory media-
tors production in macrophage-exposed AF cells2. Na€ıve AF
cells did not secrete IL-6, IL-8, PGE2, and PGF2a, while
macrophage-exposed AF cells produced these inﬂammatory
mediators at basal conditions (IL-6, 12.90 3.4 ng/ml, IL-8,
14.4 5.2 ng/ml, PGE2, 12.2 5.4 ng/ml, and PGF2a,
1.8 0.6 ng/ml) [Fig. 3(A)]. The AF cell secretion of these in-
ﬂammatory mediators was enhanced by 10 ng/ml TNF-
a (na€ıve AF cells: IL-6, 9.8 4.5 ng/ml, IL-8, 10.3 3.0 ng/
ml, PGE2, 13.5 6.5 ng/ml, and PGF2a, 0.8 0.7 ng/ml,
macrophage-exposed AF cells: IL-6, 50.3 4.7 ng/ml, IL-8,
62.7 11.6 ng/ml, PGE2, 25.6 4.2 ng/ml, and PGF2a,
11.3 1.5 ng/ml) [Fig. 3(A)]. In macrophage-exposed AFcells, the fold increases in IL-6 (4.2), IL-8 (4.4), and PGF2a
(3.9) responses were greater than that of PGE2 (2.1) when
compared to basal conditions.INHIBITION OF INFLAMMATORY MEDIATOR PRODUCTION IN
TNF-a STIMULATED AF CELLS BY SB202190SB202190 decreased CM levels of IL-6, IL-8, PGE2, and
PGF2a from both na€ıve and macrophage-exposed AF cell
activated with 10 ng/ml TNF-a [Fig. 3(B, C) and Table I].
At 0.1 mM SB202190, IL-6 (43% decrease), IL-8 (44%),
PGE2 (59%), and PGF2a (83%) were signiﬁcantly de-
creased compared to basal conditions in na€ıve AF cells,
while the responses were less striking in macrophage-ex-
posed AF cells (IL-6, 21%, IL-8, 21%, PGE2, 6%, and
PGF2a: 22%). At 1 mM SB202190, PGE2 (89%), and
PGF2a (99%) were successfully suppressed relative to
basal conditions in na€ıve AF cells. The responsiveness to
1 mM SB202190 in macrophage-exposed AF cells (IL-6,
36%, IL-8, 40%, PGE2, 51%, and PGF2a, 85%) was also
less than in na€ıve AF cells [Fig. 3(B vs C)].SECRETION OF VEGF IN CO-CULTURE AND TNF-a
STIMULATED AF CELLSVEGF levels were strikingly increased in the CM of co-cul-
ture group (9305.1 322.4 pg/ml), while AF (703.9
 12.2 pg/ml) or macrophage-like (1434.5 156.3 pg/ml)
cells alone produced much less [Fig. 4(A)]. SB202190 at
0.1, 1, and 10 mMconcentrations did not suppressVEGFpro-
duction in the co-cultured group [Fig. 4(B)]. We compared
VEGF CM concentrations of na€ıve and macrophage-ex-
posed AF cells to determine whether macrophage-like cells
inﬂuenced AF cell VEGF production in response to TNF-
a stimulation. Na€ıve AF cells did not secrete VEGF, andmac-
rophage-exposed AF cells produced VEGF at basal condi-
tions (1071.0 110.7 pg/ml). Na€ıve AF cell VEGF secretion
was enhanced by 10 ng/ml TNF-a (533.0 69.6 pg/ml),
while TNF-a blunted VEGF production in
Fig. 2. (A and B) Secretion of inﬂammatory mediators in co-culture. Human AF cells were co-cultured with macrophages for 72 h as previously
described. IL-6, IL-8, PGE2, and PGF2a were strikingly increased in the CM of co-culture group (AFM) when compared to AF cells or mac-
rophage-like cells (M) alone. Values were the meanSE of three independent experiments. *P< 0.05. (C and D) Inhibitory effects of
SB202190 on inﬂammatory mediators in co-culture. AF cells and macrophage-like cells were co-cultured for 72 h with media in presence
of 0.1 mM, 1 mM, and 10 mM SB202190 and CM were collected for the measurement of IL-6, IL-8, PGE2, and PGF2a production.
SB202190 decreased IL-6, PGE2, and PGF2a levels in a dose-dependent manner from the co-cultured group and did not suppress IL-8
production. Values were the mean SE of three independent experiments. *P< 0.05 vs 0 mM SB202190.
1665Osteoarthritis and Cartilage Vol. 17, No. 12macrophage-exposed AF cells (69%) compared to basal
conditions. SB202190 decreased VEGF production of na€ıve
AF cells activated with TNF-a in a dose-dependent manner
and did not decrease production in macrophage-exposed
AF cells [Fig. 4(C)].DNA CONTENTDNA content was assayed to conﬁrm that the results
were not inﬂuence by either proliferation or cell death. There
were no signiﬁcant differences in DNA content of AF cells
with or without previous macrophage exposure. Pro-inﬂam-
matory cytokines (10 ng/ml TNF-a) slightly increased the
DNA content (w20%) of AF cells with previous macrophage
exposure (data not shown). Therefore, macrophage-like
cells and pro-inﬂammatory cytokines minimally inﬂuenced
AF cell growth and death in these experiments.Discussion
Most treatments do not address the causes of discogenic
back pain due to a lack of mechanistic understanding of the
etiology22,23. We previously reported that IL-6 and IL-8 werestrikingly enhanced by co-culture of macrophage-like cells
with AF cells. Previous macrophage exposure up-regulated
AF cell IL-6 and IL-8 production in response to TNF-a, clin-
ically representing repeated injury at the annulus. In present
study, we conﬁrmed the presence of IL-6/IL-8 and VEGF
production in co-culture as well as in macrophage-exposed
AF cells, and demonstrated that PGs could be lessened by
p38 MAPK inhibition, which has implications in the control
of painful disc disease. Our study demonstrated the efﬁcacy
of p38 MAPK inhibition to blunt inﬂammatory reactions in
co-culture of AF and macrophage-like cells in vitro.
SB202190 successfully depressed IL-6 secretion in the
co-culture group as well as TNF-a-activated AF cells. IL-6
is involved in the development and maintenance of inﬂam-
matory reactions in disease24. Further, IL-6 is a contributor
to osteoarthritis pathological processes as it increases in-
ﬂammatory cells in synovial tissue, stimulates chondrocyte
proliferation, ampliﬁes IL-1 effects to increased matrix met-
alloprotease (MMP) synthesis, and inhibits proteoglycan
production25,26. IL-6 additionally participates in regulation
of nerve growth factor release from neural tissue27 and
evokes allodynia and neuropathic pain in animal studies28.
AF cells co-cultured with macrophages produced large
amounts of IL-6 in the present study and this production
Fig. 3. (A) Secretion of inﬂammatory mediators in AF cells by TNF-a stimulation. We compared the CM concentration of IL-6, IL-8, PGE2, and
PGF2a in na€ıve and macrophage-exposed AF cells to determine whether macrophage-like cells inﬂuenced AF cells. Na€ıve AF cells (AF(U))
did not secrete IL-6, IL-8, PGE2, and PGF2a while macrophage-exposed AF cells (AF(M)) produced these inﬂammatory mediators at basal
conditions. AF cells secretion of these inﬂammatory mediators was enhanced by 10 ng/ml TNF-a. *P< 0.05. (B and C) Inhibitory effects of
SB202190 in inﬂammatory mediators in TNF-a stimulated AF cells. SB202190 decreased the level of IL-6, IL-8, PGE2, and PGF2a measured
in CM from na€ıve AF cells as well as in macrophage-exposed AF cells (except PGs level in 0.1 mM) in the presence of 10 ng/ml TNF-a. Values
were meanSE of three independent experiments. *P< 0.05 vs 0 mM SB202190.
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1 mM SB202190 depressed IL-6 production by 36% after
TNF-a stimulation in macrophage-exposed AF cells while
na€ıve AF cells had a much sensitive response.
IL-8 is produced by neutrophils, macrophages, endothelial
cells, AF cells, cancer cells, and a variety of other cells2,29. It
possesses mitogenic activity, enhances endothelial prolifera-
tion and migration, and promotes angiogenesis30,31. IL-8 alsoTable
Inhibitory effect of SB202190 in 10 n
0 mM
AF(U) IL-6 9.8 4.6
IL-8 10.3 3.0
PGE2 13.5 6.5
PGF2a 0.8 0.7
AF(M) IL-6 50.3 4.7**
IL-8 62.7 11.6**
PGE2 25.6 4.2**
PGF2a 5.7 2.1**
AF(U): Macrophage-unexposed (na€ıve) AF cells. AF(M): Macrophagecanup-regulate focal adhesionkinaseexpression,which is the-
orized tobeanearly stepof discdegeneration innucleuspulpo-
sus cells32. Macrophage-AF cell co-cultures secreted large
amounts of IL-8, as did AF cells stimulated with TNF-a/IL-1b2.
p38 MAPK is important for activation of transcription factors
and induction of IL-8 production in a human synovial sarcoma
cell line33. Other studies have suggested that p38 MAPK is im-
plicated in IL-8 mRNA stabilization34. On the contrary, ourI
g/ml TNF-a stimulated AF cells
0.1 mM 1 mM
5.6 2.6* 4.2 2.8*
5.7 1.7* 4.3 0.6*
5.6 2.7* 1.5 0.0*
0.1 0.1* 0.0 0.0*
39.9 5.6*,** 32.3 5.3*,**
49.3 7.8*,** 37.6 9.4*,**
24.0 6.2** 12.6 3.6*,**
4.4 1.5** 0.9 0.3*,**
-exposed AF cells. *: P< 0.05 vs 0 ng/ml, **: P< 0.05 vs AF(U).
Fig. 4. Secretion of VEGF in co-culture and TNF-a stimulated AF cells. (A) VEGF was strikingly increased in the co-culture group (AFM) CM
while AF or macrophage-like cells (M) produced relatively low amounts. *P< 0.05 (B) SB202190 did not suppress VEGF production in the co-
cultured group. *P< 0.05 vs AF or M. (C) We compared VEGF CM concentrations of na€ıve and macrophage-exposed AF cells to determine
whether macrophage-like cells inﬂuenced AF cell VEGF production. Na€ıve AF cell (AF(U)) secretion of VEGF was enhanced by 10 ng/ml TNF-
a, while TNF-a blunted VEGF production in macrophage-exposed AF cells(AF(M)). SB202190 decreased VEGF production of na€ıve AF cells
to TNF-a stimulation in a dose-dependent manner. Values were the meanSE of three independent experiments. *P< 0.05 vs 0 mM
SB202190.
1667Osteoarthritis and Cartilage Vol. 17, No. 12results suggest that thep38MAPKpathway is not critical to IL-8
induction/synthesis in the co-culture groups. Considered with
IL-6 results, many other signaling pathways such as JNK/
stress-activated protein kinase (SAPK) pathway and transcrip-
tion factorsNF-kappaB, couldbe involved in themechanismsof
cytokines production35, a thorough assessment of the role for
these signal pathways remains for future studies.
In chondrocytes, PGE2 causes worsening of local inﬂam-
matory osteoarthritis symptoms36, and PGE2-accelerated
cartilage degradation occurs through the inhibition of pro-
teoglycan biosynthesis. Allodynia, a prominent feature of
neuropathic pain and inﬂammation, can also be induced
by PGE2 and PGF2a through capsaicin-sensitive ﬁbers or
insensitive ﬁbers37. Therefore, PGE2 and PGF2a might
be potential mediators for the development of discogenic
pain. Na€ıve AF and macrophage-like cells did not produce
detectable PGs in the present study while AF cells by
TNF-a stimulation secreted large amounts of PGE2 and
PGF2a. This response was enhanced by macrophage ex-
posure, suggesting that hypersensitization may occur in
the disc through PG mediated inﬂammatory reactions.p38 activates PLA2 through its downstream MAPK-211.
PLA2 activation results in arachidonic acid genesis and ca-
talysis by COX to produce PGE2 and PGF2a. SB202190 in-
hibition of basal PGE2 production in AF cells is similar to
that seen in human NP cells15, conﬁrming p38 MAPK in-
volvement in prostanoid metabolism in disc tissue and rais-
ing the possibility of blunting the production this factor
associated with painful disc degeneration38,39. PGE2 and
PGF2a accumulation decreased with increasing concentra-
tion of p38 MAPK inhibitor in the present study. SB202190
(10 mM) drastically depressed PGE2 (89%) and PGF2a
(94%) production in the co-culture group, suggesting that
SB202190 can be an effective inhibitor to blunt PG activa-
tion, which might occur in acute inﬂammatory reactions after
annular tearing.
The angiogenic factor, VEGFmay participate in the inﬂam-
matory reactions of human articular chondrocytes. Further,
p38 MAPK signals VEGF production in articular chondro-
cytes40. In this study, the p38 MAPK signaling pathway
was important for TNF-a induced VEGF production in na€ıve
AF cells while macrophage-exposed/activated AF cells use
1668 J. H. Kim et al.: p38 MAPK inhibition in annulus ﬁbrosusalternate pathways such as cytokines production. In symp-
tomatic discs, growth of ﬁne unmyelinated sensory nerves
for peripheral pain sensitization follows angiogenesis like
a wide variety of tissues41,42, and new VEGF-induced vessel
formation may facilitate pain through structural disc reorgani-
zation, although the role of angiogenesis in discogenic pain
is still unclear. Our data suggest that p38 inhibitor might
have no effect to suppress angiogenesis in discogenic low
back pain involving macrophage exposure.
Our studies demonstrated that IL-6, IL-8, PGE2, PGF2a,
and VEGF secretion are enhanced by co-culture of macro-
phage-like and AF cells. Macrophage-like cells up-regulate
TNF-a stimulated AF cell production of inﬂammatory medi-
ators and down-regulate VEGF production. p38 MAPK inhi-
bition partially blunted IL-6 secretion in co-culture and but
did not depress IL-8, suggesting that p38 MAPK is not the
primary signal for IL-8 induction in this tissue. IL-6, IL-8,
PGE2, PGF2a, and VEGF release was inhibited by the
p38 MAPK inhibitor in na€ıve AF cells stimulated by TNF-
a, and macrophages blunted these inhibitory effects.
PGE2 and PGF2a production was inhibited by the p38
MAPK inhibitor in a dose-dependent manner in the co-cul-
ture group and in macrophage-exposed AF cells. This sug-
gests that the p38 MAPK signaling pathway is strongly
associated with PGs production. Blocking/inhibiting p38
might diminish PGs and thus minimize their action to mod-
ulate proprioception, a mechanism separate from interfer-
ence with VEGF/angiogenesis mediated discogenic pain.Conﬂict of interest
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